Merrimack to sell off its cancer drugs, slashes workforce by 80%

January 08, 2017 at 21:08 PM EST

Merrimack Pharmaceuticals Inc. agreed to sell oncology assets including the pancreatic cancer drug Onivyde to French drug maker Ipsen SA.